Detailed Insights on Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) to 2030 - ResearchAndMarkets.com

Source :: Business Wire. June 4, 2020
Publication Year :: 2020
Abstract: DUBLIN -- The 'Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) - Market Insights, Epidemiology and Market Forecast - 2030' drug pipelines has been added to ResearchAndMarkets.com's [...]

Subjects :: Cabozantinib -- Reports -- Forecasts and trends
Canakinumab -- Reports -- Forecasts and trends
Small cell lung cancer -- Forecasts and trends -- Reports
Stem cells -- Reports -- Forecasts and trends
Epidemiology -- Reports -- Forecasts and trends
Non-small cell lung cancer -- Reports -- Forecasts and trends
German foreign relations
Lung cancer
Profits
Market trend/market analysis
Business
Business, international

Tools